EP1534307A1 - Zooplankton-anreicherung mit probionten und prebionten und ihre verwendung - Google Patents

Zooplankton-anreicherung mit probionten und prebionten und ihre verwendung

Info

Publication number
EP1534307A1
EP1534307A1 EP03734050A EP03734050A EP1534307A1 EP 1534307 A1 EP1534307 A1 EP 1534307A1 EP 03734050 A EP03734050 A EP 03734050A EP 03734050 A EP03734050 A EP 03734050A EP 1534307 A1 EP1534307 A1 EP 1534307A1
Authority
EP
European Patent Office
Prior art keywords
zooplankton
artemia
probionts
prebionts
brachionus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03734050A
Other languages
English (en)
French (fr)
Other versions
EP1534307A4 (de
Inventor
Moti Harel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Bionutrtion Corp
Original Assignee
Advanced Bionutrtion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Bionutrtion Corp filed Critical Advanced Bionutrtion Corp
Publication of EP1534307A1 publication Critical patent/EP1534307A1/de
Publication of EP1534307A4 publication Critical patent/EP1534307A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs

Definitions

  • the present invention relates to probiont- and prebiont-loaded zooplankton for improving health, growth, and survival rates of larval fish, fry fish, and crustaceans, by feeding them probiont- or prebiont-loaded zooplankton.
  • microbial flora is a rich ecosystem of enormous complexity containing trillions of bacteria divided into more than 400 species, in addition to yeasts, and other organisms.
  • bacteria and yeast are routinely introduced into culture medium as a normal part of food consumption (transient microflora) or as contaminants (accidental microflora).
  • the bacteria in the aquatic animal gastrointestinal tract can be divided into several functional groups; important among these are probionts, commensals and pathogens.
  • the probionts are beneficial, since they participate in a wide variety of positive and health promoting activities in fish physiology (Gildberg et al., 1997; Hansen, 2000; Irianto et al., 2000).
  • Commensals establish a community within the gut and provide continuous interaction with the intestinal contents and the animal.
  • the pathogens are harmful, as they disrupt the normal gut flora, or invade the animal to cause disease. Normally the probionts and commensals predominate within the gut, providing normal function.
  • the probionts produce many bioactive compounds, such as bacteriocins, hydrogen peroxide, lactocidin, acidophilin, and bulgarican, which have antibiotic properties inhibiting or modifying the growth of a wide spectrum of undesirable organisms, pathogens and potential pathogens.
  • the metabolic products of probionts provide many useful enzymes and volatile or non-volatile fatty acids to help digestion and absorption of certain minerals, such as phosphorus, calcium, and iron.
  • B3 niacin
  • B6 pyridoxine
  • folic acid folic acid
  • biotin folic acid
  • the lactic acid-producing bacteria confer significant protection for the fish through various immune mechanisms, which include interactions between the microbes and the host, as well as interactions among microbes.
  • Prebiotics do not colonize the gut of the target animal yet can deliver many of the same benefits derived from probionts.
  • Prebionts deliver pre-made enzymes, acids, polysaccharides, secondary metabolites, and other metabolic products that influence the composition of the intestine, as well as the overall health of the target organism.
  • Crustaceans, rotifers, nematodes, and caldocerans have been used extensively as live feeds for aquaculture, mostly for larval culture of crustaceans and fmfish (Abu-Rezq et al., 2002; Chu and Ozkizilcik, 1995; Harel et al, 1999; Shields et al., 1999). While many groups are searching for alternatives to live feeds, commercial aquaculture still relies heavily on live feeds for larviculture.
  • the present invention relates to both a composition of zooplankton loaded with probiotic or prebiotic organisms, and a method for using these specifically loaded zooplankton for aquaculture, including larviculture, in the production of crustaceans ⁇ e.g., shrimp, lobsters, red claw, and crab), mollusks (oysters and abalone), and fish ⁇ e.g., striped bass, sea bass, sea bream, carp, tilapia, catfish, trout, salmon, halibut, and yellow flounder).
  • crustaceans ⁇ e.g., shrimp, lobsters, red claw, and crab
  • mollusks oysters and abalone
  • fish ⁇ e.g., striped bass, sea bass, sea bream, carp, tilapia, catfish, trout, salmon, halibut, and yellow flounder.
  • Probiotic organisms such as Bacillus subtilis or Saccharomyces cerevisiae
  • zooplankton live feeds such as Artemia franciscana or Brachionus plicatilis, either as single cells or as microencapsulated cells or cell aggregates.
  • the feeding method depends on the maintenance of viability needs for specific probionts in the gut of the zooplankton being fed.
  • Types of microencapsulation could be a coating, such as, but not limited to, lipid, chitosan, alginate, or starch.
  • Prebiotic organisms are envisioned in this invention, and can be delivered in a manner analogous to that described for probionts, with the limitation on encapsulation being the maintenance of bioactivity provided by the specific prebiont.
  • the invention provides for zooplankton comprising at least one microencapsulated, viable, bioactive prebiotic or probiotic.
  • the zooplankton can comprise crustaceans, including those of the Artemia species, e.g., Artemia salina.
  • the zooplankton can also comprise brine shrimp, fairy shrimp, Daphina sp., Daphina magna, Streptocephalus sp., Streptocephalus dichotomus, Branchinella sp., Artemia salina, Artemia sp., Artemia parthenogenetica, Artemia franciscana, or Triops granaries.
  • the zooplankton can comprise rotifers, including those of the Brachionus species, e.g., Brachionus plicatilis, Brachionus rotundiformis, and Brachionus calyciflorus.
  • the invention further provides that the zooplankton can comprise Copepods, including Eurytemora velox.
  • the invention yet further provides that the zooplankton can comprise nematodes.
  • the invention provides that the zooplankton can comprise Panagellus redivivus. [021] The invention also provides that the zooplankton can comprise caldocerans.
  • the invention further provides that the zooplankton can comprise a Moina species.
  • probiotic and or prebiotic can be selected from fish intestinal aerobic or anaerobic microbial flora, and crustacean intestinal aerobic or anaerobic microbial flora.
  • the invention provides that the probiotic and or prebiotic can comprise a Clostridium species.
  • the invention also provides that the probiotic and or prebiotic can be selected from Aeromonas sp., Aeromonas media, Bacteriodies sp., Carnobacterium sp., Carnobacterium divergens, Carnobacterium sp.
  • strain Kl Clostridium sp., Clostridium difficile, Fusobacterium sp., Lactobacillus sp., Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus plantarum, Listonella sp., Listonella anguillarum, Bacillus sp., Bacillus cereus, Bacillus cereus var.
  • toyoi Bacillus licheniformis, Bacillus megaterium, Bacillus polymxa, Bacillus subtilis, Streptococcus sp., Streptococcus lactis, Streptococcus thermophilus, Bifidobacterium sp., Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum, Vibrio sp., Vibrio alginolyticus, Vibrio anguillarum, Vibrio carchariae, Vibrio salmonicida-like, Peptostreptococcus sp., Photobacterium sp., Pseudomonas sp., Pseudomonas corrugata, and Pseudomonas fluorescens .
  • the invention also provides that the probiotic and or prebiotic can be selected from Saccharomyces sp., Saccharomyces cerevisiae, Pfaffia sp., Pfaffia rhodomonas, Debaryomyces sp., and Debaryomyces hansenii HF1.
  • the invention further provides that the probiotic and or prebiotic can be selected from Aspergillus sp., Aspergillus oryzae, Morteriella sp., and Morteriella alpina.
  • the probiotic and or prebiotic can be selected from Tetraselmis sp., Tetraselmis suecica, Myrmecia sp., Myrmecia bissecta, Lyngbya sp., Lyngbya majuscula, Cytospora sp., Scenedesmus sp., Scenedesmus obliquus, Scytonema sp., Scytonema hofmanni, Nostoc sp., Nostoc weissfloggia, Chaetoceros sp., Chaetoceros lauderi, Ecklonia sp., Ecklonia maxima, Duneliella sp., Duneliella salina, Duneliella tertiolecta, Duneliella bardiwal, Pseudoanabaena sp., Anabaena sp., Prorocentrum sp.,
  • the invention provides a composition comprising the zooplankton of the invention, further comprising a component selected from alginate, chitosan, starch, cornstarch, and potato starch.
  • the invention provides a method for delivery of live, bioactive probionts or prebionts to larval fish, juvenile fish, and crustaceans, by providing the probionts or prebionts; and feeding them to said larval fish, juvenile fish, and crustaceans a feed or feed supplement comprising zooplankton further comprising the probionts or prebionts.
  • the invention also provides a method wherein the zooplankton are selected from crustaceans, rotifers, caldocerans, and nematodes.
  • the invention further provides a method wherein the crustaceans are selected from Artemia sp., Daphina sp., Daphina magna, Streptocephalus sp., Streptocephalus dichotomus, Branchinella sp., Artemia salina, Artemia sp., Artemia parthenogenetica, Artemia franciscana, and Triops granaries.
  • the crustaceans are selected from Artemia sp., Daphina sp., Daphina magna, Streptocephalus sp., Streptocephalus dichotomus, Branchinella sp., Artemia salina, Artemia sp., Artemia parthenogenetica, Artemia franciscana, and Triops granaries.
  • the invention yet further provides a method wherein the zooplankton are rotifers.
  • the invention provides a method wherein the rotifers are selected from Brachionus sp., Brachionus plicatilis, Brachionus rotundiformis, and Brachionus calyciflorus.
  • the invention provides a method wherein the probionts or prebionts are processed in a manner that maintains their viability.
  • the invention also provides a method wherein the probionts or prebionts are microencapsulated.
  • the invention further provides a method wherein the probionts or prebionts are mixed with alginate, chitosan, starch, cornstarch, or potato starch.
  • the invention yet further provides a method wherein the probionts or prebionts are cross-linked for stability. [039] The invention provides a method wherein the probionts or prebionts are in an encysted or resting stage.
  • the invention provides a method wherein the microcapsules with the probionts or prebionts are sized to a diameter of from about 2 to about 20 microns.
  • the invention also provides a composition wherein the zooplankton are produced by culturing on nutrient culture media comprising probiont- or prebiont-containing microcapsules.
  • the invention also provides a method of culturing the zooplankton on nutrient culture media comprising probiont- or prebiont-containing microcapsules.
  • a "probiont” is an organism that grows stably or transiently in the intestine of the target animal.
  • a “probiotic” is a general term applied to the use of probionts to deliver benefit to the target animal.
  • Prebiotic refers to an organism grown in such a method to contain one or several compounds that provide a specific health or nutritional benefit to the target animal.
  • a “target animal” as contemplated herein refers to a cultured animal to which a probiotic and/or prebiotic is developed and which provides some health or nutritional benefit.
  • a “zooplankton” (plural) or “zooplankter” (singular) as contemplated herein, is an organism or organisms belonging to the animal kingdom, found in the water, including either a fresh water or seawater column,. Examples of zooplankton include, but are not limited to, crustaceans, Artemia, rotifers, caldocerans, nematodes, copepods, and ciliates. Zooplankton can adapt to pelagic (open water), littoral (vegetated), and benthic (bottom) environments, and are widespread in both freshwater and marine environments.
  • a "crustacean” is any organism of the class Crustacea.
  • a "rotifer” is any of a class of minute, usually microscopic, but many-celled aquatic invertebrate animals having the anterior end modified into a retractile disk bearing circles of strong cilia that often give the appearance of rapidly revolving wheels. Rotifers are used as a source of live feed for aquatic animals during their early larval stage.
  • Articleemia include any strain belonging to the phylum Arthropoda in the class Crustacea. They are also referred to as "brine shrimp.” These tiny crustaceans can be found in salt lakes and brine ponds throughout the world, and are used as a source of live feed for aquatic animals.
  • a "copepod” is any organism of the subclass Copepoda.
  • a "nematode” is any organism of the phylum Nematoda.
  • Bioactivity is the ability to affect a living organism.
  • An “encysted” stage is a period of time in the course of a process in which an organism is enclosed in a small capsule or sac that encloses it in its dormant or larval stage.
  • a “resting stage” is not equivalent to the encysted stage since capsule formation is not included in the cells preparation for lower metabolism, h the resting stage the cell has lowered metabolism compared to actively growing organisms.
  • a "caldoceran” is an organism formerly grouped in the branchiopod crustacean group.
  • the caldocerans are in the class Branchiopoda, subclass diplostraca, order caldocera and family Daphniidae mainidae. Examples of caldocerans are Daphnina magana, D. galeata, D. pulex and Bosmina logirostins.
  • Microencapsulation refers to coating, containing, or incorporating in a matrix an organism or organisms in another compound or mixture of compounds such that a cell or aggregate of cells (homogeneous or a mixture) is sealed within a matrix (liquid, solid or gel) that may be used to conveniently deliver the cell or cell aggregate as described in this invention. Any process that binds up the materials to be provided to the zooplankter for eventual consumption by the target organism is contemplated herein.
  • load is used synomously with the term “enrich” for the purposes of this invention.
  • zooplankter are fed materials that are taken orally but are not meant for metabolism by the zooplankter, rather to be maintained intact in the gastrointestinal tract and consumed by the target species as a mode of delivery of the material provided to the zooplankter.
  • Clostridium difficile spores fed directly to Artemia nauplii [061] Clostridium difficile is cultured using standard anaerobic techniques and allowed to form spores (Holdeman and Moore, 1975). Anaerobic medium for growth of Clostridium is made using the following recipe: 1.75 g K 2 HPO 4 , 0.01 g CaCl 2 '2H 2 O, 0.2 g MgSO 4 » 7H 2 O, 0.01 g FeSO 4 « 7H 2 O, 2.0 g L-arginine HC1, 2.0 g L-lysine HC1, 5.0 g yeast extract, 2.0 g sodium formate, 2.0 g NH C1, 0.002 g methylene blue, and 1 L tap water.
  • the spores are mixed with an enrichment supplement for Artemia (such as AquaGrow Enhance ® ) as a dried mix or provided as an oil emulsion (mixed with water/oil/Tween 80 and spores in a Beadbeater ® or sonicator) and fed to Artemia nauplii (Cure et al., 1996).
  • an enrichment supplement for Artemia such as AquaGrow Enhance ®
  • oil emulsion mixed with water/oil/Tween 80 and spores in a Beadbeater ® or sonicator
  • Example 2 Clostridium difficile spores delivered to rotifers in bioencapsulated format.
  • Clostridium difficile spores are produced as in Example 1. h a reduced medium, alginate is added at from 1 to 8% and dissolved. Calcium chloride at 2-20% is added to induce cross-linking of the gel and the microbeads are spray dried through a fine nozzle to form microencapsulated beads containing spores.
  • Microencapsulated spores can be added to zooplankton cultures as a top dressing to existing feeds or mixed directly into the culture medium for Artemia consumption. Once the medium has been cleared, typically in 4-16 hours, preloaded Artemia can be used to introduce viable C. difficile spores into larval fish and crustaceans by direct feeding using the Artemia of this invention as live feed.
  • Example 3 Prebiont delivery to rotifers.
  • Clostridium difficile spores are produced as in Example 1. Rotifers are cultured in seawater or artificially made seawater at a salinity of 15-40 psu and
  • Example 4 Microencapsulation of Lactobacillus fermentum in alginate.
  • Lactobacillus fermentum spores are mixed with 1-3% of an emulsifying agent such as phosphatidyl choline, Tween 80, or Santone, and vortexed vigorously to produce a fine emulsion.
  • the emulsion is blended at 10-50% into sodium alginate (1-3%) and cornstarch (1-5%) in deionized water.
  • the resultant probiont in gel blend is then atomized through a spray nozzle assembly pressurized with nitrogen gas, into a bath of chilled solution containing 2-20% calcium chloride and 1-5% sodium chloride.
  • the resultant microcapsules are sieved through 20 ⁇ m
  • Example 5 Microencapsulation of Vibrio alginolyticus in alginate plus additional components.
  • Vibrio alginolyticus are produced as in Example 4, microencapsulated and dried into a fine powder.
  • AquaGrow ARA and 2-20% of fine powder of Vibrio alginolyticus are formulated and packed under nitrogen for later use as zooplankton enrichment feed.
  • Example 6 Feeding probiont-loaded rotifers to shrimp larvae.
  • Example 8 Feeding probiont-loaded Artemia to sea bream larvae.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
EP03734050A 2002-06-11 2003-06-10 Zooplankton-anreicherung mit probionten und prebionten und ihre verwendung Withdrawn EP1534307A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38742102P 2002-06-11 2002-06-11
US387421P 2002-06-11
PCT/US2003/015408 WO2003103692A1 (en) 2002-06-11 2003-06-10 Zooplankton enrichment with probionts and prebionts and uses thereof

Publications (2)

Publication Number Publication Date
EP1534307A1 true EP1534307A1 (de) 2005-06-01
EP1534307A4 EP1534307A4 (de) 2007-09-05

Family

ID=29736312

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03734050A Withdrawn EP1534307A4 (de) 2002-06-11 2003-06-10 Zooplankton-anreicherung mit probionten und prebionten und ihre verwendung

Country Status (3)

Country Link
EP (1) EP1534307A4 (de)
AU (1) AU2003239484A1 (de)
WO (1) WO2003103692A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998502B2 (en) * 2008-03-24 2011-08-16 Advanced Bionutrition Corp. Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
US9205151B2 (en) 2008-03-24 2015-12-08 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1472933A1 (de) * 2003-05-01 2004-11-03 Chr. Hansen A/S Verbesserung des Gesundheits- und/oder Ernährungszustandes von Wassertieren mit Hilfe von Bacillus licheniformis
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
WO2008076975A1 (en) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
WO2008140610A2 (en) 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
EP3266448B1 (de) 2009-03-27 2022-02-16 Intervet International B.V. Impfstoffe in mikropartikelform zur oralen oder nasalen impfung und stärkung von tieren einschliesslich fischen
AU2010254235B2 (en) 2009-05-26 2015-04-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
BR112012018839B1 (pt) 2010-01-28 2020-04-14 Advanced Bionutrition Corp composição vítrea seca compreendendo um material bioativo
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
MX350047B (es) 2010-08-13 2017-08-24 Advanced Bionutrition Corp Composicion de estabilizacion de almacenamiento en seco para materiales biologicos.
US8758774B2 (en) 2012-07-20 2014-06-24 Kuwait Institute For Scientific Research Bivalent vaccine for marine fish and method for making the same
ES2517792B1 (es) * 2013-03-14 2015-09-09 Neoalgae Micro Seaweeds Products Slne Complemento nutricional simbiótico
WO2015024593A1 (en) * 2013-08-20 2015-02-26 Chr. Hansen A/S Method for growth of bacterial cells
US10716310B2 (en) 2014-03-13 2020-07-21 Phibro Animal Health Corporation Strains of bacillus for inhibiting foodborne pathogens
US20150258150A1 (en) * 2014-03-14 2015-09-17 Osprey Biotechnics, Inc. Bacillus amyloliquefaciens strain
EP3328215B1 (de) 2015-07-29 2021-07-07 Advanced BioNutrition Corp. Stabile trockene probiotische zusammensetzungen für spezielle diätverwendungen
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
US20190082719A1 (en) * 2016-03-16 2019-03-21 Kaneka Corporation Feed composition, method for manufacturing zooplankton, zooplankton, and zooplankton growth promoter and survival rate enhancer
FR3102040B1 (fr) * 2019-10-21 2023-03-31 Lille Ecole Centrale Utilisation de nanoparticules d’amidon chargees en molecules actives pour l’aquaculture
JP2022107922A (ja) * 2021-01-12 2022-07-25 住友化学株式会社 腸内細菌叢制御用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0728676B2 (ja) * 1988-04-12 1995-04-05 クロレラ工業株式会社 水産種苗の餌料生物用餌料
US5698246A (en) * 1996-01-29 1997-12-16 Cargill, Incorporated Foodstuff for and method of feeding crustaceans and fish
CN1099886C (zh) * 1999-03-19 2003-01-29 广东医学院 一种抗鼻咽癌药物及其制备方法
CN1251388A (zh) * 1999-03-22 2000-04-26 山东农业大学 微胶囊包被益生素
US6399118B1 (en) * 2001-06-29 2002-06-04 Fish Biotech Ltd. Process for storing enriched nematodes

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE TCM [Online] SIPO; 26 April 2000 (2000-04-26), SHANDONG AGRICULTURE UNIVERSITY; FEEDSTUFF SUPERVISION OFFICE OF SHANDONG PROVINCE: "Probiotics Microcapsule" XP002438996 Database accession no. CN-99112136-A & CN 1 251 388 A (UNIV SHANDONG AGRICULTURE [CN]) 26 April 2000 (2000-04-26) *
DATABASE WPI Week 198948 Derwent Publications Ltd., London, GB; AN 1989-352039 XP002439037 & JP 01 262758 A (CHLORELLA KOGYO KK) 19 October 1989 (1989-10-19) *
DATABASE WPI Week 200103 Derwent Publications Ltd., London, GB; AN 2001-016799 XP002439010 & CN 1 267 532 A (GUANGDONG MEDICAL COLLEGE) 27 September 2000 (2000-09-27) *
KOO SUN-MO ET AL: "IMPROVEMENT OF THE STABILITY OF LACTOBACILLUS CASEI YIT 9018 BY MICROENCAPSULATION USING ALGINATE AND CHITOSAN" JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, KOREAN SOCIETY FOR APPLIED MICROBIOLOGY, SEOUL, KO, vol. 11, no. 3, June 2001 (2001-06), pages 376-383, XP009085485 ISSN: 1017-7825 *
LUCIA-PAVON E ET AL: "EFFECT OF DIFFERENT DENSITIES OF LIVE AND DEAD CHLORELLA VULGARIS ON THE POPULATION GROWTH OF ROTIFERS BRACHIONUS CALYCIFLORUS AND BRACHIONUS PATULUS (ROTIFERA)" REVISTA DE BLOGIA TROPICAL, UNIVERSIDAD DE COSTA RICA, SAN JOSE, CR, vol. 49, no. 3-4, September 2001 (2001-09), pages 895-902, XP001536351 ISSN: 0034-7744 *
MONTANARI MARIA PIA ET AL: "Vibrios associated with plankton in a coastal zone of the Adriatic Sea (Italy)" July 1999 (1999-07), FEMS MICROBIOLOGY ECOLOGY, VOL. 29, NR. 3, PAGE(S) 241-247 , XP009085491 ISSN: 0168-6496 * the whole document * *
OZKIZILCIK S ET AL: "EVALUATION OF OMEGA-3 FATTY ACID ENRICHMENT OF ARTEMIA NAUPLII AS FOOD FOR STRIPED BASS MORONE SAXATILIS WALBAUM LARVAE" JOURNAL OF THE WORLD AQUACULTURE SOCIETY, vol. 25, no. 1, 1 March 1994 (1994-03-01), pages 147-154, XP000560087 *
See also references of WO03103692A1 *
SKJERMO J ET AL: "Techniques for microbial control in the intensive rearing of marine larvae" AQUACULTURE, AMSTERDAM, NL, vol. 177, no. 1-4, July 1999 (1999-07), pages 333-343, XP002964199 *
VERSCHUERE L ET AL: "PROBIOTIC BACTERIA AS BIOLOGICAL CONTROL AGENTS IN AQUACULTURE" MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 64, no. 4, December 2000 (2000-12), pages 655-671, XP009085480 ISSN: 1092-2172 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998502B2 (en) * 2008-03-24 2011-08-16 Advanced Bionutrition Corp. Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
US9205151B2 (en) 2008-03-24 2015-12-08 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

Also Published As

Publication number Publication date
AU2003239484A1 (en) 2003-12-22
EP1534307A4 (de) 2007-09-05
WO2003103692A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
WO2003103692A1 (en) Zooplankton enrichment with probionts and prebionts and uses thereof
Farzanfar The use of probiotics in shrimp aquaculture
Dash et al. The addition of probiotic bacteria to microbial floc: water quality, growth, non-specific immune response and disease resistance of Cyprinus carpio in mid-Himalayan altitude
Carnevali et al. Administration of probiotic strain to improve sea bream wellness during development
JP2006506065A (ja) ワムシ、幼生エビおよび海産濾過食性動物の培養に適する餌料
CN108996711A (zh) 一种含丁酸梭菌的水产养殖用复合微生态制剂及其制备方法
Saad et al. Growth response of the freshwater prawn, Macrobrachium rosenbergii (De Man), to diets having different levels of Biogen®
Yuhana et al. The nutritional value of Artemia sp. enriched with the probiotic Pseudoalteromonas piscicida and the prebiotic mannan-oligosaccharide
WO2021144172A1 (en) Bacillus strains with the ability to degrade inorganic nitrogen compounds
Onianwah et al. Microorganisms in sustainable aquaculture development
Haris et al. The use of commercial feed and microdiets incorporated with probiotics in Penaeid shrimp culture: a short review
Chat et al. Synbiotics of Pediococcus pentosaceus and Fructooligosaccharide enhances the growth rate, enzymatic digestion, feed efficiency, hematological profiles, and lysozyme activity of Golden Rabbitfish (Siganus guttatus)
Campa-Córdova et al. Growth, survival, and superoxide dismutase activity in juvenile Crassostrea corteziensis (Hertlein, 1951) treated with probiotics
Fernandez et al. Effect of lactic acid bacteria administered orally on growth performance of Penaeus indicus (H. Milne Edwards) juveniles
SAHANDI et al. Effect of possible probiotic strains on suppression of Vibrio and enhancement of growth in rotifer, Brachionus plicatilis
CN1579200A (zh) 一种多效微生物饲料添加剂及其制备方法
Gupta et al. Effect of dietary probiotic improval (Lactobacillus sporogenes and Saccharomyces cerevisiae) on growth and feed utilization of Macrobrachium rosenbergii post larvae
JP2022545739A (ja) 魚用飼料添加物製剤ならびにその製造方法および使用方法
CN114128808A (zh) 助消化的鱼类液体饲料添加剂及其制备方法和应用
KR100857771B1 (ko) 바실러스 폴리퍼멘티쿠스, 바실러스 리케니포르미스 및사카로마이세스 세르비지에를 포함하는 어류사료첨가용조성물
WO2014115112A1 (en) Production of probiotics for use in the aquaculture of abalone
Soltani Effects of bioencapsulated Daphnia magna with Saccharomyces cerevisiae on the growth and feeding performance of Persian sturgeon (Acipenser persicus) larvae
CN115590119A (zh) 一种对虾专用生物饲料添加剂及其制备方法
KR101323873B1 (ko) 성장률이 우수한 나노클로롭시스 속 신균주 및 이의 용도
KR101903275B1 (ko) 신규미생물 락토바실러스 플란타룸 cjl-159 또는 이를 포함하는 어류용 사료첨가제

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050106

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070807

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071106